Beauty Is A Pain: FDA Cites Latisse Web Site For Implying Drug Is A Cosmetic

Allergan's consumer Web site for its eyelash growth drug, Latisse,certainly caught FDA's eye, leading the agency to issue a Sept. 10 "untitled" letter that cautions against promoting a drug like a cosmetic